Future prospects in biologic therapy for systemic lupus erythematosus.
about
The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manRegulation of tumour necrosis factor signalling: live or let dieA meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those withoutType I interferon in the pathogenesis of lupus.Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.In-/off-label use of biologic therapy in systemic lupus erythematosus.The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr miceC-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosusHuman embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritisInducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus.Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.Advances in understanding the role of type I interferons in systemic lupus erythematosus.Biologic therapies in systemic lupus erythematosus.B cells biology in systemic lupus erythematosus-from bench to bedside.Transgenic overexpression of BAFF regulates the expression of immune-related genes in zebrafish, Danio rerio.Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.Update on Biologic Therapies for Systemic Lupus Erythematosus.Overview of pathophysiology and treatment of human lupus nephritis.Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
P2860
Q26825196-73FFB490-8394-4D38-827C-395847FB9002Q28262381-3DC7634E-38FB-4851-8C89-AED1B203847CQ31142463-BCC6C73E-1B60-49A5-A9C3-A7621A2143DDQ33852174-3F4B84B7-E166-400C-9D77-26FAA05B1663Q34650870-C00B8739-3331-4A26-B93B-EF83AFD343E2Q35094536-5355D6C4-77E6-4252-A998-94FD9CB975D4Q35538362-14653F03-83EA-44BF-B572-6D1395A30592Q35613065-F40F90A6-071F-4260-AD72-E770BAEEEC10Q36196097-637460CE-5A9E-43D6-A055-7DDA51D0FD98Q36340132-48EEF01A-9808-46A5-8DB6-441011323DC9Q36811763-D4643E79-684F-46F6-AFA9-7D4FF1B1F6E8Q37514840-BCE7A422-4108-4F90-80F2-CEE15F3A952BQ38227972-28E74C6A-D8CF-4015-9756-2D27ED42C8C6Q38425831-71F06D60-003F-4D3F-B59C-969AF8DAA045Q38631964-513382CC-166C-40FB-AC11-030DF75FB77EQ38725378-B5A04E29-C170-4F18-98C9-86D03382C047Q38748557-6DFA7B7D-6E77-4AE1-8800-174DF01B7BEDQ38864797-1E04D60D-5207-4CC4-BD3F-84D44D6756B9Q38876110-A9889A83-B5FE-4CCF-B7CB-554EA8E4068EQ39218839-07132DA8-874A-4EAC-85DF-A3E465C68C58Q39379152-E9E1CEA4-F98A-4E60-94C9-5707D5F0B2BCQ52639397-31820427-7F6B-4AC5-BBB4-D38832896EC4
P2860
Future prospects in biologic therapy for systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Future prospects in biologic therapy for systemic lupus erythematosus.
@en
type
label
Future prospects in biologic therapy for systemic lupus erythematosus.
@en
prefLabel
Future prospects in biologic therapy for systemic lupus erythematosus.
@en
P2860
P356
P1476
Future prospects in biologic therapy for systemic lupus erythematosus.
@en
P2093
William Stohl
P2860
P2888
P304
P356
10.1038/NRRHEUM.2013.136
P407
P577
2013-09-10T00:00:00Z
P6179
1034010361